心血管疾病更新:慢性冠状动脉疾病的医疗管理
Anthony M Recidoro1, Joseph M Sapoval2, Kevin A Bobeck3
1Camp Pendleton Family Medicine Residency Program, Marine Corps Base Camp Pendleton, CA.
FP essentials
|August 19, 2025
概括
慢性冠状动脉疾病管理侧重于生活方式的改变和药物治疗,以改善生活质量和寿命. 指南导向治疗旨在减少心脏事件和减缓动脉样硬化进展.
科学领域:
- 心脏病学 心脏病学
- 血管医学 血管医学
背景情况:
- 慢性冠状动脉疾病 (CCD),以前是稳定的缺血性心脏病,涉及冠状动脉中的斑块积累.
- 诊断通常依赖于检测心肌缺血的功能性非侵入性测试.
研究的目的:
- 概述慢性冠状动脉疾病的诊断方法和管理策略.
- 强调改善患者生活质量和延长寿命的目标.
主要方法:
- 使用功能性非侵入性测试,如压力心声学,心脏核磁共振和SPECT来诊断阻塞性冠状动脉疾病.
- 管理包括生活方式优化,风险因素控制 (高脂血症,高血压,糖尿病) 和药物治疗.
主要成果:
- 指南导向医学疗法旨在减少心脏死亡,缺血事件和动脉样硬化进展.
- 在患者管理中应考虑社会经济因素.
结论:
- 慢性冠状动脉疾病的综合管理包括生活方式改变,风险因素控制和基于证据的药物治疗.
- 解决社会经济决定因素对于有效的患者护理和资源分配至关重要.
相关概念视频
Acute Coronary Syndrome IV: Interprofessional Care
26
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
26
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Angina IV: Management
22
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
22
Coronary Artery Disease V: Interprofessional Care
30
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30
Rheumatic Heart Disease III: Medical Management
32
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
32
Angina V: Nursing Management
45
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
45


